Jonathan Bond

12PUBLICATIONS
29CO-AUTHORS
Molecular targetsHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Respiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Dec 03, 2025
Reduced PRC2 function causes asparaginase resistance in T-ALL by decreasing WNT pathway activity.

Thomas Lefeivre, Theodora-Ioana Grosu, Cosmin Tudose

|Jul 29, 2025
Enhancer heterogeneity in acute lymphoblastic leukemia drives differential gene expression in patients.

Alastair L Smith, Nicholas Denny, Catherine Chahrour

|Jul 14, 2025
A structure-based modelling approach identifies effective drug combinations for RAS-mutant acute myeloid leukemia.

Luke Jones, Oleksii Rukhlenko, Tânia Dias

|May 24, 2021
Immature acute leukaemias: lessons from the haematopoietic roadmap.

Thomas Lefeivre, Luke Jones, Amélie Trinquand

Pageof 2